Alpha Lipoic Acid for Neuropathy: Dosage, Benefits, and What the Research Says

Alpha lipoic acid gets mentioned in almost every neuropathy conversation I have had in the last two years. Unlike many supplements that get borrowed from other conditions, ALA has been studied directly in people with diabetic peripheral neuropathy for decades. The evidence is not theoretical.

Here is what that evidence actually shows, what dose to take, and the one detail on the label that most people overlook.

Key Takeaways

• A meta-analysis of randomized controlled trials found ALA significantly reduced total neuropathic symptom scores in diabetic patients (PubMed, 2012).
• The NATHAN 1 trial found 600mg ALA daily for 4 years produced clinically meaningful improvement and prevented neuropathy progression (PMC).
• R-ALA is the biologically active form and more bioavailable than standard racemic ALA, the label matters.
• For oral use, 600mg daily in two 300mg doses is the most supported protocol for long-term diabetic neuropathy management.

Why ALA Matters for Nerve Damage

Peripheral neuropathy in diabetic patients is driven significantly by oxidative stress. Prolonged high blood glucose generates free radicals that damage nerve cell membranes, impair energy production in nerve mitochondria, and reduce blood flow to peripheral nerves. ALA is one of the few antioxidants that works inside both fat-soluble and water-soluble cellular compartments, making it uniquely effective at reaching nerve tissue.

Beyond antioxidant activity, ALA improves endoneural blood flow, the circulation inside nerve tissue itself. Reduced endoneural blood flow is one of the earliest measurable changes in diabetic neuropathy. Restoring it does not reverse existing damage, but it can slow progression and allow existing nerves to function better.

I had my nerve conduction velocity tested twice: once before supplementation and once sixteen months after starting ALA. The second test showed improvement in my motor nerve conduction. My neurologist was genuinely surprised given the timeline of my diagnosis.

What the Clinical Trials Show

A 2012 meta-analysis published in Diabetic Medicine found ALA supplementation significantly reduced total neuropathic symptom scores compared to placebo across multiple randomized controlled trials (PubMed). This was pooled analysis, not a single study.

The NATHAN 1 trial followed 460 patients with mild to moderate diabetic peripheral neuropathy for four years on 600mg ALA daily. It found clinically meaningful improvement in neuropathic impairments and prevention of progression (PMC). Four years of consistent improvement is not a small finding.

A 2020 randomized double-blind placebo-controlled trial testing oral 600mg ALA once daily found significant improvement in neuropathy symptom scores versus placebo (PubMed). The oral route works, not just IV infusion.

A 2025 systematic review and meta-analysis confirmed these findings while noting that IV ALA at 600mg/day produces faster initial improvement (3 weeks), while oral dosing at 600mg or more daily requires 3 to 6 months for clinically relevant changes (Exploration Pub).

R-ALA vs Standard ALA: The Label Detail Most People Miss

Standard ALA supplements contain a 50/50 mixture of R-ALA and S-ALA. Only the R form is biologically active. Your body produces R-ALA naturally. The S form is synthetic and competes with R-ALA for absorption.

R-ALA alone (stabilized R-ALA) has significantly higher bioavailability than the same milligram dose of racemic ALA. In practical terms, 300mg of stabilized R-ALA delivers more active compound to your nerve tissue than 600mg of standard ALA.

When reading supplement labels: “Alpha lipoic acid” or “ALA” without specification means a racemic mixture (50% active). “R-ALA,” “R-alpha lipoic acid,” or “stabilized R-alpha lipoic acid” means the biologically active form only. If the price difference between two ALA products seems large, check whether one is R-ALA and the other is racemic, you may not be comparing equivalent doses.

What Dose of ALA Should You Take for Neuropathy?

The most consistent clinical trial dosing is 600mg per day of racemic ALA, which translates to approximately 300mg per day of stabilized R-ALA for equivalent activity.

Racemic ALA: 600mg daily, split into two 300mg doses with meals. Stabilized R-ALA: 300mg daily, split into two 150mg doses. Take ALA with a meal that contains some fat, ALA is partially fat-soluble and fat improves absorption. ALA can reduce blood glucose levels moderately, so if you are on insulin or oral diabetes medications, monitor blood glucose more closely when starting and discuss with your physician.

How Long Before ALA Works for Neuropathy?

This is where most people stop too early. The clinical trials showing IV ALA improvement used daily infusions at clinics over 3 weeks. That is not the same as taking capsules at home.

For oral supplementation: nighttime cramps and sleep sometimes improve in 3 to 4 weeks. Meaningful pain score reduction typically takes 8 to 12 weeks. Nerve conduction improvement requires 6 to 12 months of consistent use. ALA is not a pain medication, it does not produce the same immediate relief as gabapentin. The benefit is progressive reduction in damage and improved nerve function over months.

ALA in a Full Neuropathy Protocol

ALA alone addresses oxidative stress and blood flow. A complete protocol also needs methylcobalamin B12 for myelin repair, see Best Vitamin B12 for Nerve Damage, and magnesium for NMDA receptor pain amplification, see Magnesium for Neuropathy.

For a multi-compound approach, I take Arialief, which combines R-ALA with other neuropathy-targeted compounds in research-supported doses. Full breakdown in the Arialief review.

Affiliate disclosure: I receive a commission if you purchase through my Arialief link. This does not affect my assessment.

Frequently Asked Questions

Is alpha lipoic acid safe for long-term use?

The NATHAN 1 trial followed patients on 600mg ALA daily for four years with a good safety profile. The most common side effects at higher doses are nausea and digestive discomfort, which taking it with food reduces significantly. No serious long-term safety concerns are documented at typical supplemental doses.

Can ALA reverse neuropathy?

ALA can improve neuropathy symptoms and slow progression. Complete reversal depends on how much nerve damage has already occurred and whether the underlying cause is controlled. Early intervention while damage is mild to moderate produces better outcomes than starting after severe nerve loss.

Should I take ALA in the morning or at night?

Split the dose: one with breakfast, one with dinner. This maintains more consistent plasma levels throughout the day and reduces gastrointestinal side effects compared to a single large dose.

Does ALA interact with diabetes medications?

ALA can potentiate the glucose-lowering effect of insulin and oral hypoglycemics. Separate ALA from thyroid medications by at least 4 hours. Always review potential interactions with your pharmacist when starting any new supplement.

Conclusion

Alpha lipoic acid is backed by more clinical trial evidence for diabetic peripheral neuropathy than almost any other supplement available. The key variables are form (R-ALA beats racemic ALA), dose (600mg racemic or 300mg R-ALA daily), and timeline (8 to 12 weeks for symptom change, months for nerve function improvement).

For a full picture of which supplements have the best evidence for nerve damage, see my complete guide to neuropathy supplements.

If you’re considering ALA supplements, also review our guide on Arialief side effects and drug interactions before starting.

Medical Disclaimer: The information in this article is for educational purposes only and does not constitute medical advice. Mark Whitfield is not a medical professional. Always consult your physician before starting any supplement regimen, especially if you take medications or have a chronic health condition.